Stockscreener 앱 받기
50.27
0.52%
0.26
시간 외 거래:
50.27
전일 마감가:
$50.01
열려 있는:
$49.9
하루 거래량:
453.03K
Relative Volume:
0.47
시가총액:
$2.42B
수익:
$1.35B
순이익/손실:
$163.34M
주가수익비율:
15.34
EPS:
3.2763
순현금흐름:
$189.17M
1주 성능:
-1.84%
1개월 성능:
-0.44%
6개월 성능:
-21.27%
1년 성능:
-29.67%
1일 변동 폭
$49.23
$50.33
1주일 범위
$48.98
$51.00
52주 변동 폭
$47.31
$94.98
Haemonetics Corp Stock (HAE) Company Profile
명칭
Haemonetics Corp
전화
(781) 848-7100
주소
125 SUMMER STREET, BOSTON, MA
HAE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HAE
Haemonetics Corp
|
50.27 | 2.41B | 1.35B | 163.34M | 189.17M | 3.2763 |
|
ABT
Abbott Laboratories
|
123.84 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.59 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
358.16 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.20 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.07 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-08-08 | 재확인 | Barrington Research | Outperform |
| 2025-08-08 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-09 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-06-26 | 개시 | Robert W. Baird | Outperform |
| 2025-02-07 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-12-06 | 개시 | JP Morgan | Overweight |
| 2024-11-08 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-09-13 | 개시 | CL King | Buy |
| 2024-09-11 | 개시 | BofA Securities | Neutral |
| 2024-09-10 | 개시 | BTIG Research | Buy |
| 2024-06-12 | 업그레이드 | Needham | Hold → Buy |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-01-27 | 다운그레이드 | Needham | Buy → Hold |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-08-17 | 재개 | Raymond James | Outperform |
| 2021-06-17 | 개시 | Citigroup | Buy |
| 2021-05-14 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2021-04-20 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-04-19 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2021-02-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-01-21 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-11-05 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-03-31 | 업그레이드 | CJS Securities | Market Perform → Market Outperform |
| 2020-01-10 | 개시 | Needham | Buy |
| 2019-08-07 | 재확인 | Barrington Research | Outperform |
| 2019-05-14 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2019-05-08 | 재확인 | Barrington Research | Outperform |
| 2018-08-09 | 재확인 | Barrington Research | Outperform |
| 2018-02-07 | 재확인 | Barrington Research | Outperform |
| 2018-01-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2017-11-08 | 재확인 | Barrington Research | Outperform |
| 2017-08-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2017-07-13 | 업그레이드 | JMP Securities | Mkt Perform → Mkt Outperform |
| 2017-02-07 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-11-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2016-11-07 | 재확인 | The Benchmark Company | Hold |
| 2016-09-20 | 다운그레이드 | CJS Securities | Market Outperform → Market Perform |
| 2016-08-15 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-08-02 | 재확인 | Jefferies | Buy |
| 2016-08-02 | 재확인 | The Benchmark Company | Hold |
모두보기
Haemonetics Corp 주식(HAE)의 최신 뉴스
Is Haemonetics Corporation stock dividend growth reliableRate Cut & Weekly Market Pulse Updates - newser.com
When is the best time to exit Haemonetics CorporationRate Hike & Precise Swing Trade Entry Alerts - newser.com
Published on: 2025-11-02 20:37:56 - newser.com
Can Haemonetics Corporation (HAZ) stock test all time highsJuly 2025 Pullbacks & Daily Stock Trend Watchlist - newser.com
How Haemonetics Corporation stock benefits from digital adoptionJuly 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Haemonetics (HAE) to Release Earnings on Thursday - MarketBeat
Using RSI to spot recovery in Haemonetics Corporation2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Is Haemonetics Corporation (HAZ) stock prepared for digital transitionMarket Sentiment Summary & AI Forecast for Swing Trade Picks - newser.com
Will Haemonetics Corporation (HAZ) stock issue positive guidanceMarket Trend Report & Free Technical Confirmation Trade Alerts - newser.com
Is Haemonetics Corporation stock a defensive play in 2025Earnings Growth Report & Precise Swing Trade Entry Alerts - newser.com
Haemonetics Corporation (HAE) Stock forecasts - Yahoo! Finance UK
Haemonetics Corporation (HAE) Stock Forecasts - Yahoo Finance
How Recent Developments Are Shaping the Haemonetics Investment Story - Yahoo Finance
Using data filters to optimize entry into Haemonetics CorporationQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - newser.com
Can Haemonetics Corporation stock weather global recessionEarnings Risk Summary & Detailed Earnings Play Alerts - newser.com
Using AI based signals to follow Haemonetics CorporationTrade Exit Report & Safe Entry Zone Identification - newser.com
Can Haemonetics Corporation stock outperform in 2025 bull marketEarnings Performance Report & Capital Efficiency Focused Strategies - fcp.pa.gov.br
Will Haemonetics Corporation stock outperform value stocks2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
What the charts say about Haemonetics Corporation todayWeekly Trend Recap & Technical Confirmation Alerts - newser.com
Will Haemonetics Corporation (HAZ) stock sustain bullish trend into 2025Market Performance Recap & Consistent Profit Alerts - newser.com
Haemonetics Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Riverwater Partners LLC Sells 5,091 Shares of Haemonetics Corporation $HAE - MarketBeat
Does Haemonetics Corporation fit your quant trading modelJuly 2025 Earnings & Consistent Growth Equity Picks - newser.com
Haemonetics (NYSE:HAE) Cut to Sell (D+) at Weiss Ratings - MarketBeat
Haemonetics Corp (HAE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.84%
0.40%
자본화:
|
볼륨(24시간):